Key Insights

Highlights

Treatment Research

2 treatments under study, led by Fluorescein Sodium

Research Leaders

5 sponsors active, led by Insel Gruppe AG, University Hospital Bern

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT02756091Recruiting

International Intracranial Dissection Study

NCT02028325Phase 4Terminated

Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions

Showing all 2 trials

Research Network

Common Treatments

  • Fluorescein Sodium1
  • No Studyspecific Intervention1

Active Sponsors

  • Insel Gruppe AG, University Hospital Bern1
  • Indiana University1
  • Cervical Artery Dissections and Ischemic Stroke Patients - Consortium1
  • Sentara Norfolk General Hospital1
  • Swiss Heart Foundation1

Top Investigators

Related Conditions

  • Intimal Dissection1
  • Stroke1
  • Adult Intracranial Neoplasm1
  • Cerebrovascular Disorders1

Activity Timeline